跳转至内容
Merck
  • Sexual dimorphism in the meiotic requirement for PRDM9: A mammalian evolutionary safeguard.

Sexual dimorphism in the meiotic requirement for PRDM9: A mammalian evolutionary safeguard.

Science advances (2020-10-25)
Natalie R Powers, Beth L Dumont, Chihiro Emori, Raman Akinyanju Lawal, Catherine Brunton, Kenneth Paigen, Mary Ann Handel, Ewelina Bolcun-Filas, Petko M Petkov, Tanmoy Bhattacharyya
摘要

In many mammals, genomic sites for recombination are determined by the histone methyltransferase PRMD9. Some mouse strains lacking PRDM9 are infertile, but instances of fertility or semifertility in the absence of PRDM9 have been reported in mice, canines, and a human female. Such findings raise the question of how the loss of PRDM9 is circumvented to maintain fertility. We show that genetic background and sex-specific modifiers can obviate the requirement for PRDM9 in mice. Specifically, the meiotic DNA damage checkpoint protein CHK2 acts as a modifier allowing female-specific fertility in the absence of PRDM9. We also report that, in the absence of PRDM9, a PRDM9-independent recombination system is compatible with female meiosis and fertility, suggesting sex-specific regulation of meiotic recombination, a finding with implications for speciation.

材料
货号
品牌
产品描述

Sigma-Aldrich
单克隆抗 β-微管蛋白抗体 小鼠抗, clone TUB 2.1, ascites fluid